This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Biogen Options Trade on Takeover Rumors

David Russell, analyst at OptionMonster.

Stock and options traders are piling into Biogen Idec (BIIB - Get Report) on speculation that the drugmaker could be a takeover target.

About 75,000 options contracts traded on the name, more than 10 times the average over the last 20 sessions. About two-thirds of the volume is in calls, according to OptionMonster's tracking systems.

Most of the buying is focused on options expiring this month and next. Some 21,500 contracts have changed hands for the April 55 strikes, plus another 13,400 for the April 60 strikes. Both contracts, plus the May 60 calls, traded in volumes that exceeded open interest.

Biogen Idec stock rose 6.5% today to $52.85 on volume of about 6.4 million, almost twice the average level. Rumors circulated among European trading desks suggested French pharmaceuticals giant Sanofi-Aventis may offer to buy Biogen for at least $75 a share, according to Reuters.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
BIIB $401.71 0.00%
AAPL $130.28 0.00%
FB $81.53 0.00%
GOOG $565.06 0.00%
TSLA $218.42 0.00%

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs